Replication organelles of hepatitis C virus and SARS-CoV-2: Surprising similarities and avenues for broad-spectrum antivirals

被引:0
|
作者
Roingeard, Philippe [1 ,2 ,3 ,4 ]
机构
[1] Univ Tours, Inserm, MAVIVH, U1259, 10 Blvd Tonnelle, F-37032 Tours, France
[2] Univ Tours, Plateforme IBiSA Microscopie Elect, 10 Blvd Tonnelle, F-37032 Tours, France
[3] CHU Tours, 10 Blvd Tonnelle, F-37032 Tours, France
[4] Inserm, Fac Med Tours, MAVIVH, U1259, 10 Blvd Tonnelle, F-37032 Tours, France
来源
关键词
COVID-19; Severe acute respiratory syndrome; Hepatitis C; RNA virus infections; Virus replication; Antiviral agents; CORONAVIRUS REPLICATION; ENDOPLASMIC-RETICULUM; PROTEINS; RNA;
D O I
10.1016/j.banm.2023.10.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Positive single -strand RNA (+RNA) viruses can remodel host cell membranes to induce replication organelles isolating the replication of their genome from cellular innate immunity mechanisms. Some of these viruses, including the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), induce double-membrane vesicles (DMV) to behave as replication organelles. As for the hepatitis C virus (HCV), pores crossing both membranes of SARS-CoV-2-induced DMV have been identified. These pores likely allow the supply of metabolites essential for viral replication within the DMV, and allow the export of the newly synthesized viral RNA to form the genome of the neo-synthesized virions. However, it remains unknown whether DMV with open pores can coexist with fully sealed DMV allowing the storage of large amounts of viral RNA, as seen for the HCV model. Interestingly, recent studies have revealed many similarities in the mechanisms of DMV biogenesis between these two phylogenetically distant viruses. Understanding the mechanisms of DMV formation and function will be essential for the development of new broad-spectrum antiviral approaches, able to inhibit DMV-inducing viruses from different families. (c) 2023 l'Academie nationale de medecine. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 50 条
  • [41] Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
    Wen, Kun
    Cai, Jian-Piao
    Fan, Xiaodi
    Zhang, Xiaojuan
    Luo, Cuiting
    Tang, Kai-Ming
    Shuai, Huiping
    Chen, Lin-Lei
    Zhang, Ricky Ruiqi
    Situ, Jianwen
    Tsoi, Hoi-Wah
    Wang, Kun
    Chan, Jasper Fuk-Woo
    Yuan, Shuofeng
    Yuen, Kwok-Yung
    Zhou, Hongwei
    To, Kelvin Kai-Wang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [42] A SARS-CoV-2 EG.5 mRNA vaccine induces a broad-spectrum immune response in mice
    Wang, Hongyu
    Peng, Qinhua
    Dai, Xinxian
    Ying, Zhifang
    Wu, Xiaohong
    Liu, Xinyu
    Xu, Hongshan
    Li, Jia
    Shi, Leitai
    Liu, Jingjing
    Wang, Yunpeng
    Zhao, Danhua
    Huang, Yanqiu
    Yang, Lihong
    Yang, Ren
    Yue, Guangzhi
    Suo, Yue
    Ye, Qiang
    Cao, Shouchun
    Li, Yuhua
    MEDCOMM, 2025, 6 (01):
  • [43] The α-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped viruses
    Bigotti, Maria Giulia
    Klein, Katja
    Gan, Esther S.
    Anastasina, Maria
    Andersson, Simon
    Vapalahti, Olli
    Katajisto, Pekka
    Erdmann, Maximilian
    Davidson, Andrew D.
    Butcher, Sarah J.
    Collinson, Ian
    Ooi, Eng Eong
    Balistreri, Giuseppe
    Brancaccio, Andrea
    Yamauchi, Yohei
    ANTIVIRAL RESEARCH, 2024, 224
  • [44] Virtual screening reveals liquiritigenin as a broad-spectrum inhibitor of SARS-CoV-2 variants of concern: an in silico study
    Ahmed, Sheikh Sunzid
    Al-Mamun, Abdullah
    Hossain, Shah Imran
    Akter, Farzana
    Ahammad, Ishtiaque
    Chowdhury, Zeshan Mahmud
    Salimullah, Md
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (14): : 6709 - 6727
  • [45] A peptide derived from SARS-CoV-2 nucleocapsid protein with broad-spectrum anti-coronavirus activity
    Ye, Guoguo
    Tang, Yimin
    Yang, Qin
    Zhang, Chenhui
    Shi, Huiping
    Wang, Jun
    Hu, Xiao
    Wan, Xiaofu
    Xu, Zhixiang
    Liang, Jinhu
    Yang, Yang
    Yang, Minghui
    Liu, Yingxia
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (04)
  • [46] Discovering broad-spectrum inhibitors for SARS-CoV-2 variants: a cheminformatics and biophysical approach targeting the main protease
    Alqahtani, Safar M.
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [47] mRNA vaccines with RBD mutations have broad-spectrum activity against SARS-CoV-2 variants in mice
    Liang, Xiaoming
    Yuan, Yuxia
    Wang, Junbin
    Tang, Cong
    Yang, Yun
    Zhou, Yanan
    Yang, Hao
    Huang, Qing
    Yu, Wenhai
    Wang, Haixuan
    Yan, Yuhuan
    Lin, Dongdong
    Li, Yanwen
    Du, Xuena
    Yuan, Longhai
    Quan, Wenqi
    Wu, Daoju
    Lu, Shuaiyao
    NPJ VACCINES, 2025, 10 (01)
  • [48] Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants
    Tan, Shudan
    Zhao, Jinghua
    Hu, Xue
    Li, Yufeng
    Wu, Zihan
    Lu, Guoliang
    Yu, Zhaoli
    Du, Binhe
    Liu, Yan
    Li, Li
    Chen, Yuchen
    Li, Ye
    Yao, Yanfeng
    Zhang, Xiaoyu
    Rao, Juhong
    Gao, Ge
    Peng, Yun
    Liu, Hang
    Yuan, Zhiming
    Liu, Jia
    Wang, Qianran
    Hu, Hengrui
    Gao, Xiaobo
    Zhou, Hui
    Yu, Hang
    Xu, Yingjie
    Yu, Wei
    Feng, Lin
    Wang, Manli
    Shan, Chao
    Lu, Jing
    Lin, Jinzhong
    SCIENCE BULLETIN, 2023, 68 (24) : 3192 - 3206
  • [49] SARS-CoV-2: Virus Replication in the upper Respiratory Tract
    Gappa, Birgit
    TRANSFUSIONSMEDIZIN, 2020, 10 (03) : 132 - +
  • [50] Methotrexate inhibits SARS-CoV-2 virus replication "in vitro"
    Caruso, Arnaldo
    Caccuri, Francesca
    Bugatti, Antonella
    Zani, Alberto
    Vanoni, Marco
    Bonfanti, Paolo
    Cazzaniga, Marina E.
    Perno, Carlo F.
    Messa, Cristina
    Alberghina, Lilia
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1780 - 1785